PMID: 2100164Jan 1, 1990Paper

Toxicity of intraocular daunomycin

Lens and Eye Toxicity Research
P Wiedemann, K Heimann

Abstract

Due to its antiproliferative properties, daunomycin is of potential use in the treatment of proliferative vitreoretinopathy and capsular fibrosis after cataract extraction. Previous biomicroscopic, electrophysiologic and histologic studies in the rabbit had shown that higher drug doses caused damage to all ocular structures after exposure to daunomycin. Based on the animal studies, we concluded that there is a small but usable therapeutic window for this drug. As electrophysiology and histology are not readily available for the examination of the human silicone-filled eye, we used clinical examination and fluorescein angiography as toxicity parameters. The comparison of the visual acuity and the central visual field showed that visual acuity is a reliable parameter of retinal and macular function after vitreoretinal surgery. Any specific toxicity attributable to daunomycin could not be observed in our patients. We conclude that the daunomycin perfusion (7.5 mg/l for 10 min.) is well tolerated by the human eye.

Related Concepts

Related Feeds

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.